The Prostate Cancer Charity comments on new research into a vaccine that claims to cure prostate cancer in mice

The Prostate Cancer Charity comments on new research published in the journal, Nature Medicine, which suggests that a new vaccine could cure prostate tumours in mice, with no apparent side effects.

Dr Kate Holmes, Research Manager at The Prostate Cancer Charity, explains: "Treating cancer by provoking a response from the body's immune system has been a strong focus for research for many years and this new study, which uses multiple pieces of prostate DNA, has yielded some promising results.

"The danger of using this type of therapy is that it can produce an excessive immune response - meaning that the injected virus attacks healthy cells as well as the prostate cancer. Significantly, the vaccine developed in this study has shown to not cause any damage to normal, healthy cells in mice whilst helping to kill the prostate tumour.

"This study provides new hope for the potential of these new anti-cancer therapies. Although we are hopeful that the results of this study could help to form the basis of a new cancer vaccine in future, it is important to remember that the researchers have only investigated the potential of their vaccine in mice. Further research looking at its effect in men is needed before we can be sure of the usefulness of this vaccine. We look forward to the outcome," she added.